Recorded fact · drug.label_indication
drug.label_indication for belzutifan|renal-cell-carcinoma
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 86f5d32b resolves to.
The record
| Fact id | 86f5d32be71ab4aeb8d41b74 |
|---|---|
| Entity | drug: belzutifan|renal-cell-carcinoma |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260612 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
(VHL) disease for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immedia
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 28eaaf4e24810e0fd2a9a52a18ed563582cd6b0f82252a33a780c1412c10e07e.
The value
{
"ingredient": "Belzutifan",
"conditionId": "renal-cell-carcinoma",
"conditionName": "Renal Cell Carcinoma",
"matchedAlias": "renal cell carcinoma",
"context": "indication",
"brand": "WELIREG",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "13e15ee0-d679-4fa9-9430-e2e2170474da",
"labelEffectiveTime": "20260612",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 03b90d5d7be7450aa61a2d46d3a65605c5e3bbcc312940017d75c1f72dd391f7.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.